Are Medinova Diagno. latest results good or bad?
Medinova Diagnostic Services' latest results for Q3 2025 show a decline, with net sales down 8.09% and net profit reduced by 22.73%, indicating a slowdown in growth and efficiency compared to the previous quarter.
Medinova Diagnostic Services has reported its financial results for the quarter ending September 2025, showing a notable decline in key metrics compared to the previous quarter ending June 2025. The net sales experienced a decrease of 8.09%, while the consolidated net profit saw a reduction of 22.73%. In terms of operational performance, the operating profit (PBDIT) also reflected a decline of 13.21%, indicating a shift in profitability dynamics. The operating profit margin, which stood at 36.80% in June, saw a contraction of 2.17%.
Despite these challenges, the company had previously reported a strong performance in June 2025, with the highest operating profit and net profit figures recorded in the last five quarters. However, the latest results suggest a slowdown in growth and efficiency, particularly highlighted by the drop in the inventory turnover ratio, which was the lowest in the last five half-yearly periods.
Additionally, the company has experienced an adjustment in its evaluation over the recent months, reflecting the changes in its financial performance. Overall, the results indicate a shift in operational trends for Medinova Diagnostic Services, warranting close attention to future developments.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
